Specific dynamic action of food in patients with chronic pancreatitis accompanied with metabolic syndrome


如何引用文章

全文:

详细

Aim. To study hormone component of food specific dynamic action (FSDA) in chronic pancreatitis (CP) accompanied with metabolic syndrome (MS).
Material and methods. A total of 60 patients were examined: 30 patients with CP and 30 patients with CP accompanied with MS. The study of fasting levels of thyrotrophic hormone, thyroxin, cortisol, insulin, C-peptide was conducted as well as one and two hours after carbohydrate breakfast to assess development of FSDA.
Results. The study revealed that development of FSDA is characterized by systemic reaction, including changes in multiple hormonal parameters. However, patients with CP accompanied with MS demonstrated abnormal basal secretion and postprandial secretory responses of the above hormones. The absence of hormonal responses to food intake impairs FSDA and thus is involved in pathogenesis of metabolic disorders in patients with CP accompanied with MS.
Conclusion. The study of the development of FSDA brings valuable information that can be used in clinical practice for studying mechanisms of metabolic disorders in various pathological conditions.

作者简介

Yakov Vakhrushev

Anna Volkova

Email: annalogi@mail.ru

Ya Vakhrushev

State Medical Academy, Izhevsk

State Medical Academy, Izhevsk

A Volkova

State Medical Academy, Izhevsk

State Medical Academy, Izhevsk

参考

  1. Егорова Е. Г., Звенигородская Л. А., Лазебник Л. Б. Метаболический синдром с позиции гастроэнтеролога. Рус. мед. журн. 2005; 13 (26): 1706-1712.
  2. Корочина И. Э. Гастроэнтерологические аспекты метаболического синдрома. Рос. журн. гастроэнтерол., гепатол., колопроктол. 2008; 18 (1): 26-34.
  3. Христич Т. Н., Кендзерская Т. Б. Поджелудочная железа при метаболическом синдроме. Экспер. и клин. гастроэнтерология 2010; 8: 83-91.
  4. Лазебник Л. Б., Звенигородская Л. А. Метаболический синдром и органы пищеварения. М.: Анахарсис; 2009.
  5. Вахрушев Я. М. Специфическое динамическое действие пищи. Ижевск: Экспертиза; 1996.
  6. Уголев А. М. Энтериновая (кишечная гормональная) система. Л.: Наука; 1978.
  7. Рекомендации экспертов ВНОК по диагностике и лечению метаболического синдрома / Чазова И. Е., Мычка В. Б., Кисляк О. А. и др. Второй пересмотр. М.; 2009.
  8. Reaven G. M. Insulin resistance and compensatory hyperinsulinemia role in hypertension, dyslipidemia and coronary heart disease. Am. Heart J. 1991; 1: 1283-1288.
  9. Reaven G. M. The metabolic syndrome: is this diagnosis necessary? Am. J. Clin. Nutr. 2006; 83 (6): 1237-1247.
  10. Чазова И. Е., Мычка В. Б. Метаболический синдром. М.: Медиа Медика; 2008.
  11. Yu Chin Cheng, Hua Hsu Ai, Qin Alex, Tong Chin. Neuroendocrine mechanisms in the pathophysiology of obesity. J. Psychiatr. Biol. Ther. 1990; 36: 26-33.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Consilium Medicum, 2012

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


##common.cookie##